20 May 2013
Keywords: singulair, approved, use, younger, children, merck, co
Article | 08 March 2000
Merck & Co's leukotriene inhibitor Singulair (montelukast sodium) hasbeen approved in the USA in a new 4mg tablet formulation for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 March 2000
7 March 2000
17 May 2013
© 2013 thepharmaletter.com